Cesare Battaglia — Endo Lab

article 2014

·doi:10.1159/000362646

AIMS: To estimate the recurrence rate of patients with endometrial polyps and to evaluate whether the recurrence can be correlated with the histopathologic features of the polyp. METHODS: Two hundred and eighty-two women with endometrial po…

article 2005

Vascular endothelial growth factor and its soluble receptor in ovarian pathology

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology ·doi:10.1080/09513590500099560

OBJECTIVE: The soluble form of the vascular endothelial growth factor (VEGF) receptor, s-VEGFR-1, may negatively regulate the action of VEGF. Our purpose was to better understand the regulation of angiogenetic processes in ovarian cysts. ME…

article 2002

Vascular endothelial growth factor, interleukin-6 and interleukin-2 in serum and follicular fluid of patients with ovarian hyperstimulation syndrome

·doi:10.1016/s0301-2115(01)00568-1

BackgroundThe pathogenesis of ovarian hyperstimulation syndrome (OHSS) is not completely understood.ObjectiveTo investigate the presence of VEGF, IL-6 and IL-2, in serum and follicular fluid, in patients developing severe OHSS.Study designW…

article 1995

A comparative, randomized study of three different progesterone support of the luteal phase following IVF/ET program

·doi:10.1007/bf03349699

The use of luteal phase support has been demonstrated in patients undergoing IVF/ET in cycles stimulated after pituitary desensitization with gonadotrophin releasing hormone agonists. However, it is still not clear which is the most suitabl…